Early skin tumor detection with telemedicine in primary care
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1440 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Institute of Health Information and Statistics of the Czech Republic Government |
| Locations | 5 sites (Brno and 4 other locations) |
| Trial ID | NCT07349940 on ClinicalTrials.gov |
What this trial studies
This is a national, prospective, multicenter, single-arm pilot that will train 18 general practitioners and link them with 6 dermatology centers to use a telemedicine tool for screening skin tumors. About 1,440 participants with at least one suspicious lesion and phototype I or II will have images and clinical data reviewed remotely by affiliated dermatologists. The project will develop a standardized methodology, set up workflows for GP–dermatologist collaboration, and test integration of the process into the health-care system. Findings will be used to propose system-level changes to improve screening efficiency and referral pathways.
Who should consider this trial
Good fit: Ideal candidates are people in the Czech Republic with at least one suspicious skin lesion, phototype I or II, who have not had a dermatologist skin examination in the past 12 months and can visit a participating GP site.
Not a fit: People with darker skin types (phototype III or higher), those without any suspicious lesions, or those already examined by a dermatologist within the last 12 months are unlikely to benefit from this pilot.
Why it matters
Potential benefit: If successful, the project could enable earlier detection of skin cancers and more efficient referrals from primary care to dermatology, reducing delays and unnecessary in-person visits.
How similar studies have performed: Previous teledermatology studies have shown good diagnostic accuracy and improved access to dermatology care, though national-scale implementation pilots are less common.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least 1 suspected lession * phototype I or phototype II Exclusion Criteria: * skin lession examination by dermatologist in last 12 months * unsigned consent to participate in the project and consent to the processing of personal data
Where this trial is running
Brno and 4 other locations
- St. Anne's University Hospital Brno — Brno, Czechia (Not_yet_recruiting)
- Olomouc University Hospital — Olomouc, Czechia (Recruiting)
- University Hospital Pilsen — Pilsen, Czechia (Not_yet_recruiting)
- Bulovka University Hospital — Prague, Czechia (Recruiting)
- University hospital Kralovske Vinohrady — Prague, Czechia (Not_yet_recruiting)
Study contacts
- Study coordinator: Dagmar Obšilová, Msc
- Email: dagmar.obsilova@uzis.cz
- Phone: +420606429382
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.